The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus

Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3 CD31 CXCR4 T cells (T ), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the co...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 572876
Main Authors Bortoluzzi, Alessandra, Chighizola, Cecilia Beatrice, Fredi, Micaela, Raschi, Elena, Bodio, Caterina, Privitera, Daniela, Gonelli, Arianna, Silvagni, Ettore, Govoni, Marcello, Cavazzana, Ilaria, Airò, Paolo, Meroni, Pier Luigi, Tincani, Angela, Franceschini, Franco, Piantoni, Silvia, Casciano, Fabio
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 29.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3 CD31 CXCR4 T cells (T ), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a T subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between T subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and T subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)- were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects' serum stimulation were also evaluated. Results showed that the percentage of T and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28 cells among T subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to T cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of T and inversely related to the CD28 T subsets. We indirectly evaluated the role of the T subset on the endothelium upon stimulation with serum from subjects with a low percentage of T CD3 cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of T compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28 subset exerts detrimental role over the T phenotype, where T could exert an anti-inflammatory effect on endothelial cells and might orchestrate IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.
AbstractList Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3+CD31+CXCR4+ T cells (Tang), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a Tang subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between Tang subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and Tang subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)-γ were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects' serum stimulation were also evaluated. Results showed that the percentage of Tang and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28null cells among Tang subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to Tang cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of Tang and inversely related to the CD28null Tang subsets. We indirectly evaluated the role of the Tang subset on the endothelium upon stimulation with serum from subjects with a low percentage of Tang CD3+ cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of Tang compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28null subset exerts detrimental role over the Tang phenotype, where Tang could exert an anti-inflammatory effect on endothelial cells and might orchestrate via IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3+CD31+CXCR4+ T cells (Tang), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a Tang subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between Tang subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and Tang subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)-γ were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects' serum stimulation were also evaluated. Results showed that the percentage of Tang and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28null cells among Tang subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to Tang cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of Tang and inversely related to the CD28null Tang subsets. We indirectly evaluated the role of the Tang subset on the endothelium upon stimulation with serum from subjects with a low percentage of Tang CD3+ cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of Tang compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28null subset exerts detrimental role over the Tang phenotype, where Tang could exert an anti-inflammatory effect on endothelial cells and might orchestrate via IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.
Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3 + CD31 + CXCR4 + T cells (T ang ), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a T ang subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between T ang subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and T ang subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)- γ were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects’ serum stimulation were also evaluated. Results showed that the percentage of T ang and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28 null cells among T ang subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to T ang cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of T ang and inversely related to the CD28 null T ang subsets. We indirectly evaluated the role of the T ang subset on the endothelium upon stimulation with serum from subjects with a low percentage of T ang CD3 + cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of T ang compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28 null subset exerts detrimental role over the T ang phenotype, where T ang could exert an anti-inflammatory effect on endothelial cells and might orchestrate via IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.
Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3 CD31 CXCR4 T cells (T ), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a T subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between T subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and T subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)- were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects' serum stimulation were also evaluated. Results showed that the percentage of T and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28 cells among T subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to T cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of T and inversely related to the CD28 T subsets. We indirectly evaluated the role of the T subset on the endothelium upon stimulation with serum from subjects with a low percentage of T CD3 cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of T compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28 subset exerts detrimental role over the T phenotype, where T could exert an anti-inflammatory effect on endothelial cells and might orchestrate IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.
Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3+CD31+CXCR4+ T cells (Tang), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a Tang subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between Tang subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and Tang subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)-γ were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects’ serum stimulation were also evaluated. Results showed that the percentage of Tang and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28null cells among Tang subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to Tang cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of Tang and inversely related to the CD28null Tang subsets. We indirectly evaluated the role of the Tang subset on the endothelium upon stimulation with serum from subjects with a low percentage of Tang CD3+ cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of Tang compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28null subset exerts detrimental role over the Tang phenotype, where Tang could exert an anti-inflammatory effect on endothelial cells and might orchestrate via IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.
Author Raschi, Elena
Piantoni, Silvia
Tincani, Angela
Meroni, Pier Luigi
Franceschini, Franco
Gonelli, Arianna
Bodio, Caterina
Govoni, Marcello
Airò, Paolo
Fredi, Micaela
Privitera, Daniela
Bortoluzzi, Alessandra
Chighizola, Cecilia Beatrice
Silvagni, Ettore
Casciano, Fabio
Cavazzana, Ilaria
AuthorAffiliation 3 Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia , Brescia , Italy
2 Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS , Milan , Italy
4 Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara , Ferrara , Italy
1 Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria Sant’Anna , Cona , Italy
AuthorAffiliation_xml – name: 4 Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara , Ferrara , Italy
– name: 1 Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria Sant’Anna , Cona , Italy
– name: 2 Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS , Milan , Italy
– name: 3 Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia , Brescia , Italy
Author_xml – sequence: 1
  givenname: Alessandra
  surname: Bortoluzzi
  fullname: Bortoluzzi, Alessandra
  organization: Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Italy
– sequence: 2
  givenname: Cecilia Beatrice
  surname: Chighizola
  fullname: Chighizola, Cecilia Beatrice
  organization: Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Milan, Italy
– sequence: 3
  givenname: Micaela
  surname: Fredi
  fullname: Fredi, Micaela
  organization: Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy
– sequence: 4
  givenname: Elena
  surname: Raschi
  fullname: Raschi, Elena
  organization: Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Milan, Italy
– sequence: 5
  givenname: Caterina
  surname: Bodio
  fullname: Bodio, Caterina
  organization: Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Milan, Italy
– sequence: 6
  givenname: Daniela
  surname: Privitera
  fullname: Privitera, Daniela
  organization: Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Milan, Italy
– sequence: 7
  givenname: Arianna
  surname: Gonelli
  fullname: Gonelli, Arianna
  organization: Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy
– sequence: 8
  givenname: Ettore
  surname: Silvagni
  fullname: Silvagni, Ettore
  organization: Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Italy
– sequence: 9
  givenname: Marcello
  surname: Govoni
  fullname: Govoni, Marcello
  organization: Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Italy
– sequence: 10
  givenname: Ilaria
  surname: Cavazzana
  fullname: Cavazzana, Ilaria
  organization: Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy
– sequence: 11
  givenname: Paolo
  surname: Airò
  fullname: Airò, Paolo
  organization: Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy
– sequence: 12
  givenname: Pier Luigi
  surname: Meroni
  fullname: Meroni, Pier Luigi
  organization: Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Milan, Italy
– sequence: 13
  givenname: Angela
  surname: Tincani
  fullname: Tincani, Angela
  organization: Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy
– sequence: 14
  givenname: Franco
  surname: Franceschini
  fullname: Franceschini, Franco
  organization: Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy
– sequence: 15
  givenname: Silvia
  surname: Piantoni
  fullname: Piantoni, Silvia
  organization: Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy
– sequence: 16
  givenname: Fabio
  surname: Casciano
  fullname: Casciano, Fabio
  organization: Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33193356$$D View this record in MEDLINE/PubMed
BookMark eNpVks9u1DAQxiNUREvpA3BBPnLZxY4dJ-GABKsAK-0WiS1ny3Emuy6JvfWforwAz413t1StLx6Nv_l5NPO9zs6MNZBlbwmeU1rVH3o9jnGe4xzPizKvSv4iuyCcsxnNc3b2JD7Prry_xemwmlJavMrOKSUpLPhF9vdmB2i5XjfXmwZtQuymj-iYMgHcfpAT-gLhD4BBer2OBpA0HWquOxt2MGg5oAUMg0faoDV0WgZttmghXaftvfQqDtKhn9r_Pgg2kw8waoVWcR89atyUGKMM1kf_JnvZy8HD1cN9mf362twsvs9WP74tF59XM8V4EWaqIETmVLGeqZrwCqqeKKj7lrVpAkWFGcEMS0pVqThTHBdFUpFO5YQQCpxeZssTt7PyVuydHqWbhJVaHBPWbYV0QasBRJ8YZctp2zHGVE9r3tEaU5UzDBUuq8T6dGLtYztCp8AEJ4dn0OcvRu_E1t6LkqdO8QHw_gHg7F0EH8SovUrzlAZs9CJnnOC037xOUnKSKme9d9A_fkOwONhBHO0gDnYQJzukmndP-3us-L98-g_4q7PJ
CitedBy_id crossref_primary_10_1177_09612033221144596
crossref_primary_10_3389_fmed_2022_849086
crossref_primary_10_3389_fimmu_2020_617804
crossref_primary_10_3389_fimmu_2022_974826
crossref_primary_10_1016_j_intimp_2024_111788
crossref_primary_10_3390_biomedicines10040851
crossref_primary_10_3390_ijerph192214768
crossref_primary_10_1016_j_jaut_2022_102863
crossref_primary_10_1002_cti2_1427
crossref_primary_10_1021_acsomega_3c06293
crossref_primary_10_1186_s13287_022_03002_y
Cites_doi 10.1097/HJH.0000000000001940
10.3389/fimmu.2019.00941
10.1161/CIRCULATIONAHA.107.694778
10.1155/2016/2842143
10.1002/art.1780400928
10.3899/jrheum.110550
10.1097/BOR.0000000000000528
10.1111/j.1538-7836.2009.03555.x
10.1161/01.RES.0000177670.72216.9b
10.1093/oxfordjournals.aje.a009122
10.1016/j.numecd.2017.09.001
10.1177/0961203318821161
10.1016/j.clim.2017.04.001
10.3389/fimmu.2020.00529
10.1016/j.intimp.2020.106282
10.1093/rheumatology/kez264
10.1161/01.CIR.0000131450.66017.B3
10.3390/ijms18020436
10.1038/nm1452
10.1016/j.ccr.2004.09.028
10.1136/ard.2006.065631
10.1177/0961203317722848
10.1161/CIRCRESAHA.110.231837
10.1161/01.cir.101.25.2883
10.1111/joim.12357
10.1038/nprot.2007.111
10.1016/j.jacc.2007.06.040
10.1007/s00296-010-1730-9
10.2174/1874609808666150727111904
10.1189/jlb.5CE0815-335RR
10.1002/art.1780390303
10.1371/journal.pone.0009173
10.1016/j.rdc.2005.01.008
10.1172/JCI118638
10.1016/j.atherosclerosis.2013.08.008
10.3390/cells9051313
10.1371/journal.pone.0183102
10.3389/fonc.2020.00036
10.1016/j.jaut.2017.05.008
10.3389/fmed.2018.00200
10.1007/978-1-4939-6960-9_1
10.1002/art.34473
10.1111/jth.12865
10.1016/j.autrev.2017.01.009
10.1046/j.1365-2141.2001.03076.x
10.1200/JCO.2005.04.2861
10.1189/jlb.5HI0215-042R
10.1038/nrrheum.2012.16
10.1038/s41598-019-47310-5
10.1097/01.md.0000091181.93122.55
ContentType Journal Article
Copyright Copyright © 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano.
Copyright © 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano
Copyright_xml – notice: Copyright © 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano.
– notice: Copyright © 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fimmu.2020.572876
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_fc7c7b63bd444cf396d3903c240e8078
10_3389_fimmu_2020_572876
33193356
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
ITC
5PM
ID FETCH-LOGICAL-c465t-c511a23c4f4c9168e8f1ce9fb4b28758041040a33c7c64c60551681dc21113e63
IEDL.DBID RPM
ISSN 1664-3224
IngestDate Fri Oct 04 13:11:54 EDT 2024
Tue Sep 17 21:14:50 EDT 2024
Sat Aug 17 04:33:03 EDT 2024
Thu Sep 26 15:47:09 EDT 2024
Wed Oct 09 10:32:54 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords immunosenescence
systemic lupus erythematosus
angiogenic T cells
cardiovascular risk
endothelial progenitor cells
Language English
License Copyright © 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-c511a23c4f4c9168e8f1ce9fb4b28758041040a33c7c64c60551681dc21113e63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors share senior authorship
Reviewed by: Fabio Malavasi, University of Turin, Italy; Artur Augusto Paiva, Coimbra Hospital and University Center, Portugal
These authors have contributed equally to this work
Edited by: Marta Catalfamo, Georgetown University Medical Center, United States
This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658008/
PMID 33193356
PQID 2461002029
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_fc7c7b63bd444cf396d3903c240e8078
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7658008
proquest_miscellaneous_2461002029
crossref_primary_10_3389_fimmu_2020_572876
pubmed_primary_33193356
PublicationCentury 2000
PublicationDate 2020-10-29
PublicationDateYYYYMMDD 2020-10-29
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-29
  day: 29
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2020
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Petri (B14) 2012; 64
Piantoni (B42) 2018; 27
Masuda (B27) 2011; 109
Manzi (B3) 1997; 145
Wigren (B6) 2015; 278
Cavazzana (B34) 2019; 28
Miao (B35) 2016; 2016
Cervera (B5) 2003; 82
Sparmann (B44) 2004; 6
Koller (B39) 2013; 230
Gladman (B18) 1996; 39
Lynch (B16) 2018; 36
Baker (B49) 2012; 32
Papadaki (B48) 2001; 115
Gladman (B17) 2002; 29
Diani (B21) 2017; 180
Gerli (B41) 2004; 109
Della Bella (B51) 2016; 99
Liuzzo (B40) 2000; 101
Kerekes (B15) 2012; 8
Rodriguez-Carrio (B36) 2015; 74
Lv (B33) 2020; 81
Hochberg (B13) 1997; 40
Pengo (B19) 2009; 7
Tektonidou (B7) 2017; 16
Casciano (B28) 2020; 11
Hur (B10) 2007; 116
Pengo (B20) 2015; 13
Kolitz (B9) 2019; 10
Liu (B4) 2018; 30
Schmidt (B12) 1996; 97
Urowitz (B1) 2005; 31
Baragetti (B8) 2018; 28
Prabst (B30) 2017; 1601
Duda (B25) 2007; 2
Romagnani (B23) 2005; 97
Manetti (B32) 2017; 12
Raeeszadeh-Sarmazdeh (B45) 2020; 9
Du (B29) 2020; 10
Liuzzo (B38) 2007; 50
Giannelou (B2) 2017; 82
Janic (B26) 2010; 5
López (B37) 2020; 59
Duda (B24) 2006; 24
van den Hoogen (B43) 2015; 8
Westerweel (B47) 2007; 66
López (B11) 2016; 99
Edwards (B50) 2018; 5
Li (B31) 2017; 18
Hanna (B46) 2006; 12
Diani (B22) 2019; 9
References_xml – volume: 36
  start-page: 89
  year: 2018
  ident: B16
  article-title: 2018 ESC/ESH Guidelines for The Management of Hypertension
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000001940
  contributor:
    fullname: Lynch
– volume: 10
  year: 2019
  ident: B9
  article-title: Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00941
  contributor:
    fullname: Kolitz
– volume: 116
  year: 2007
  ident: B10
  article-title: Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.694778
  contributor:
    fullname: Hur
– volume: 74
  year: 2015
  ident: B36
  article-title: Angiogenic T cells are decreased in rheumatoid arthritis patients
  publication-title: Ann Rheum Dis
  doi: 10.1155/2016/2842143
  contributor:
    fullname: Rodriguez-Carrio
– volume: 40
  start-page: 1725
  year: 1997
  ident: B13
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400928
  contributor:
    fullname: Hochberg
– volume: 29
  year: 2002
  ident: B17
  article-title: Systemic lupus erythematosus disease activity index 2000
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.110550
  contributor:
    fullname: Gladman
– volume: 30
  year: 2018
  ident: B4
  article-title: Cardiovascular disease in systemic lupus erythematosus: an update
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000528
  contributor:
    fullname: Liu
– volume: 7
  year: 2009
  ident: B19
  article-title: Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardization committee of the international society on thrombosis and haemostasis
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2009.03555.x
  contributor:
    fullname: Pengo
– volume: 97
  year: 2005
  ident: B23
  article-title: CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000177670.72216.9b
  contributor:
    fullname: Romagnani
– volume: 145
  year: 1997
  ident: B3
  article-title: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a009122
  contributor:
    fullname: Manzi
– volume: 28
  start-page: 53
  year: 2018
  ident: B8
  article-title: Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2017.09.001
  contributor:
    fullname: Baragetti
– volume: 28
  year: 2019
  ident: B34
  article-title: Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors
  publication-title: Lupus
  doi: 10.1177/0961203318821161
  contributor:
    fullname: Cavazzana
– volume: 180
  start-page: 84
  year: 2017
  ident: B21
  article-title: Blood to skin recirculation of CD4(+) memory T cells associates with cutaneous and systemic manifestations of psoriatic disease
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2017.04.001
  contributor:
    fullname: Diani
– volume: 11
  year: 2020
  ident: B28
  article-title: CCR4+ Skin-Tropic Phenotype as a Feature of Central Memory CD8+ T Cells in Healthy Subjects and Psoriasis Patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.00529
  contributor:
    fullname: Casciano
– volume: 81
  year: 2020
  ident: B33
  article-title: The Risk of Circulating Angiogenic T Cells and Subsets in Patients With Systemic Sclerosis
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2020.106282
  contributor:
    fullname: Lv
– volume: 59
  year: 2020
  ident: B37
  article-title: IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile
  publication-title: Rheumatol (Oxford)
  doi: 10.1093/rheumatology/kez264
  contributor:
    fullname: López
– volume: 109
  year: 2004
  ident: B41
  article-title: CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000131450.66017.B3
  contributor:
    fullname: Gerli
– volume: 18
  start-page: 436
  year: 2017
  ident: B31
  article-title: Advanced Glycation End Products Inhibit the Proliferation of Human Umbilical Vein Endothelial Cells by Inhibiting Cathepsin D
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18020436
  contributor:
    fullname: Li
– volume: 12
  year: 2006
  ident: B46
  article-title: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
  publication-title: Nat Med
  doi: 10.1038/nm1452
  contributor:
    fullname: Hanna
– volume: 6
  year: 2004
  ident: B44
  article-title: Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2004.09.028
  contributor:
    fullname: Sparmann
– volume: 66
  year: 2007
  ident: B47
  article-title: Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.065631
  contributor:
    fullname: Westerweel
– volume: 27
  year: 2018
  ident: B42
  article-title: Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes
  publication-title: Lupus
  doi: 10.1177/0961203317722848
  contributor:
    fullname: Piantoni
– volume: 109
  start-page: 20
  year: 2011
  ident: B27
  article-title: Methodological development of a clonogenic assay to determine endothelial progenitor cell potential
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.110.231837
  contributor:
    fullname: Masuda
– volume: 101
  year: 2000
  ident: B40
  article-title: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes
  publication-title: Circulation
  doi: 10.1161/01.cir.101.25.2883
  contributor:
    fullname: Liuzzo
– volume: 278
  start-page: 494
  year: 2015
  ident: B6
  article-title: Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention
  publication-title: J Intern Med
  doi: 10.1111/joim.12357
  contributor:
    fullname: Wigren
– volume: 2
  year: 2007
  ident: B25
  article-title: A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.111
  contributor:
    fullname: Duda
– volume: 50
  year: 2007
  ident: B38
  article-title: Unusual CD4+CD28null T Lymphocytes and Recurrence of Acute Coronary Events
  publication-title: Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.06.040
  contributor:
    fullname: Liuzzo
– volume: 32
  start-page: 997
  year: 2012
  ident: B49
  article-title: Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-010-1730-9
  contributor:
    fullname: Baker
– volume: 8
  year: 2015
  ident: B43
  article-title: Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond
  publication-title: Curr Aging Sci
  doi: 10.2174/1874609808666150727111904
  contributor:
    fullname: van den Hoogen
– volume: 99
  start-page: 399
  year: 2016
  ident: B51
  article-title: Editorial: Senescent Angiogenic T Cells: The Use of CD28 Makes the Difference in Endothelial Homeostasis
  publication-title: Leukoc Biol
  doi: 10.1189/jlb.5CE0815-335RR
  contributor:
    fullname: Della Bella
– volume: 39
  year: 1996
  ident: B18
  article-title: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780390303
  contributor:
    fullname: Gladman
– volume: 5
  start-page: e9173
  year: 2010
  ident: B26
  article-title: Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009173
  contributor:
    fullname: Janic
– volume: 31
  year: 2005
  ident: B1
  article-title: Contributions of observational cohort studies in systemic lupus erythematosus: the university of Toronto lupus clinic experience
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2005.01.008
  contributor:
    fullname: Urowitz
– volume: 97
  year: 1996
  ident: B12
  article-title: Weyand CM CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity
  publication-title: J Clin Invest
  doi: 10.1172/JCI118638
  contributor:
    fullname: Schmidt
– volume: 230
  year: 2013
  ident: B39
  article-title: CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2013.08.008
  contributor:
    fullname: Koller
– volume: 9
  year: 2020
  ident: B45
  article-title: Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
  publication-title: Cells
  doi: 10.3390/cells9051313
  contributor:
    fullname: Raeeszadeh-Sarmazdeh
– volume: 12
  start-page: e0183102
  year: 2017
  ident: B32
  article-title: Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0183102
  contributor:
    fullname: Manetti
– volume: 10
  year: 2020
  ident: B29
  article-title: High Expression of Integrin alpha3 Predicts Poor Prognosis and Promotes Tumor Metastasis and Angiogenesis by Activating the c-Src/Extracellular Signal-Regulated Protein Kinase/Focal Adhesion Kinase Signaling Pathway in Cervical Cancer
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.00036
  contributor:
    fullname: Du
– volume: 82
  start-page: 1
  year: 2017
  ident: B2
  article-title: Cardiovascular disease in systemic lupus erythematosus: A comprehensive update
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2017.05.008
  contributor:
    fullname: Giannelou
– volume: 5
  year: 2018
  ident: B50
  article-title: Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2018.00200
  contributor:
    fullname: Edwards
– volume: 1601
  start-page: 1
  year: 2017
  ident: B30
  article-title: Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-6960-9_1
  contributor:
    fullname: Prabst
– volume: 64
  year: 2012
  ident: B14
  article-title: Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34473
  contributor:
    fullname: Petri
– volume: 2016
  year: 2016
  ident: B35
  article-title: Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus
  publication-title: Mediators Inflamm
  doi: 10.1155/2016/2842143
  contributor:
    fullname: Miao
– volume: 13
  year: 2015
  ident: B20
  article-title: Antiphospholipid syndrome: antibodies to domain 1 of β2-glycoprotein 1 correctly classify patients at risk
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.12865
  contributor:
    fullname: Pengo
– volume: 16
  year: 2017
  ident: B7
  article-title: Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2017.01.009
  contributor:
    fullname: Tektonidou
– volume: 115
  year: 2001
  ident: B48
  article-title: Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2001.03076.x
  contributor:
    fullname: Papadaki
– volume: 24
  year: 2006
  ident: B24
  article-title: Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.2861
  contributor:
    fullname: Duda
– volume: 99
  year: 2016
  ident: B11
  article-title: Senescent profile of angiogenic T cells from systemic lupus erythematosus patients
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.5HI0215-042R
  contributor:
    fullname: López
– volume: 8
  year: 2012
  ident: B15
  article-title: Validated methods for assessment of subclinical atherosclerosis in rheumatology
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2012.16
  contributor:
    fullname: Kerekes
– volume: 9
  start-page: 10870
  year: 2019
  ident: B22
  article-title: Increased frequency of activated CD8(+) T cell effectors in patients with psoriatic arthritis
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-47310-5
  contributor:
    fullname: Diani
– volume: 82
  start-page: 299
  year: 2003
  ident: B5
  article-title: European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
  publication-title: Med (Baltimore)
  doi: 10.1097/01.md.0000091181.93122.55
  contributor:
    fullname: Cervera
SSID ssj0000493335
Score 2.3817563
Snippet Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 572876
SubjectTerms Adult
angiogenic T cells
Animals
Cardiovascular Diseases - immunology
cardiovascular risk
Endothelial Cells - physiology
endothelial progenitor cells
Female
Human Umbilical Vein Endothelial Cells
Humans
Immunology
Immunophenotyping
Immunosenescence
Interleukin-8 - metabolism
Lupus Erythematosus, Systemic - immunology
Male
Risk
systemic lupus erythematosus
T-Lymphocyte Subsets - immunology
T-Lymphocytes - immunology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOil9N3tCxV6KrhZ62W7t2ZxSEu9h7aB3IQkS9Ttxhvi9WH_QH53ZqRNWJdCL73KMh70jTTfoPE3hLxjXuZWOZcFOP0yUc59ZiojM1sZzitlZB5FkpqlOjkVX87k2V6rL6wJS_LAaeEOgytcYRW3rRDCBXi_hTSdO4hEHrXS4-mby71k6lfivZxzma4xIQurDkN3fj5CPsjmH2QBaYKaBKKo1_83kvlnreRe8Dl-QO7vWCP9lKx9SO74_hG5m_pIbh-TKwCbfm6aevm9plgZuP1I41CsKFyZLT1K5Vi0a5qx99T0La2XLf59tQIHpAu_Wg2062kTO3dAOKOLSaEq_dYNv3FCUjjvHP06XowDrS-3SfZ1PYzDE3J6XP9YnGS7BguZE0puMgdsyzDuRBAOaGLpy5A7XwUrLKyQRGki2OMAGmCghIPMR8KsvHUMG9R7xZ-Sg37d--eEli0vUJ1-Ll0ubDU3ioUyWCmZZbDl_Yy8v1ltfZF0NDTkHwiNjtBohEYnaGbkCPG4nYgS2HEAHEPvHEP_yzFm5O0Nmhq2DN6DmN6vx0GjhB7SZFbNyLOE7u2nOBxJ4DhgQjHBfWLL9Enf_Yyy3AWQOWBUL_6H8S_JPVwPDJKsekUONpejfw3sZ2PfREe_Bp0HAl4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1bj5QwFG7WNZp9Md4Xb6mJTyasQ2-AiTHuhM1qZB7USfaN0FJWlGV2hyGRP-Dv9hzKbMSMr6VA6Xfa85308B1CXjErA62M8UvY_XwRzayfx7n0dZxzHqtcBoNIUrpQp0vx6Uye7ZFteatxAtudoR3Wk1qu66NfV_17WPDvMOIEf_umrC4uOgj12OxIhhABqBvkJhNcoMGnI9v_4cgw51y6s83ddx6Q2xyMEnqpiaMa9Px3kdB_cyn_ck4nd8mdkVXSD84M7pE929wnt1ydyf4B-Q3GQD-mabL4mlDMHOzf0qFpyDis854eu3QtWqVp11iaNwVNFgX-nVWDgdK5reuWVg1Nh8oe4O7ofJLISr9U7U_s4BTQK0M_d5ddS5N172RhV23XPiTLk-Tb_NQfCzD4Rii58Q2wsZxxI0phgEZGNioDY-NSCw2TJVG6CPYAANWERgkDkZGEXkFhGBawt4o_IvvNqrGHhEYFD1G9fiZNIHQ8yxUro1JLyTSDLcF65PV2trNLp7ORQXyCKGUDShmilDmUPHKMeFx3RInsoWG1Ps_GFZeVMKhQK64LIYQpwfAKHs-4AQpjUWTfIy-3aGawpPCcJG_sqmszlNhDGs1ijzx26F6_amsdHgknuE_GMr3SVN8H2e4QyB4wrif_feZTcoAfiZ6Rxc_I_mbd2edAeTb6xWDIfwBod_3N
  priority: 102
  providerName: Scholars Portal
Title The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
URI https://www.ncbi.nlm.nih.gov/pubmed/33193356
https://www.proquest.com/docview/2461002029/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC7658008
https://doaj.org/article/fc7c7b63bd444cf396d3903c240e8078
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb5wwELWSSJV6qZJ-0rSRK_VUiV3wF9BbsiJNq7Kq2kbaG8LGpLQsu1qWw_6B_O6M7SUKVU-9cDBGWH5jZgY_v0HoPdE8lEIpv4Kvn8_iQPtFUnBfJgWliSh4aEWSsrm4umZfFnxxgPhwFsaS9pWsJ22znLT1L8utXC_VdOCJTb9lswjcJviu6SE6jCh9kKL_diEvpZS7HUxIwJJpVS-XPaSCJJjwCDIEU7aIgulBLzFyR1a1_1-h5t-MyQcu6PIYPdnHjvjcjfEEHej2KXrkqknunqFbgBx_zrJ0_iPFhh-4-4htk-UVNsUOXzhSFq6zrG81LtoSp_PSnMFqwAzxTDdNh-sWZ7Z-Bzg1PBvRVfH3uvtjOjid81rhr_2673C62Tnx11XXd8_R9WX6c3bl78ss-IoJvvUVxFwFoYpVTEGwGOu4CpVOKskkTBY3AkWw0gE6FSnBFOQ_HHqFpSKmTL0W9AU6aletfoVwXNLIaNQHXIVMJkEhSBVXknMiCSx87aEPw2zna6emkUMWYlDKLUq5QSl3KHnowuBx39EIYduG1eYm35tDXsGgIimoLBljqgLzKmkSUAWBijZS-h56N6CZw8IxuyFFq1d9lxshPRMsk8RDLx26968arMND0Qj30VjGd8BWrTj33jZf__eTp-ixmQTjH0nyBh1tN71-C4HPVp7ZHwZw_bQI4Zqx-Mya_h12PQXS
link.rule.ids 230,315,733,786,790,870,891,2115,24346,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYJLeRZSXkbihJRsEtt5cKOrVFvYrBC0qDcrdhwIzWZXm81h-QH8bsb2pupWXOBqO4qT-eyZkT9_g9DbULFARFK6Fex-Lk185RZpwVyRFoSkUcECI5KUz6LJOf14wS72EBvuwhjSvhS11zZzr61_GG7lci5HA09s9Dkfx-A2wXeNbqHbsF7D-FqS_tMGvYQQZs8wIQVLR1U9n_eQDIa-x2LIEXThIgLgg1HRjkMyuv1_CzZvciavOaGT--jbMH3LPbn0-rXw5K8byo7__H0P0ME2LMUfbPdDtKfaR-iOLVS5eYx-A5rwaZ5ns68Z1tTDzXtsmgxlsSk2-NjyvXCd532rcNGWOJuV-npXAwjHY9U0Ha5bnJvSIOAv8XiHCYu_1N2lHmAl1GuJp_2y73C22lhd2UXXd0_Q-Ul2Np642woOrqQRW7sSwrkiJJJWVEIcmqikCqRKK0EFWIFp7SPYRAAVMpYRlZBaMRgVlBLS0oCoiByi_XbRqmcIJyWJtfy9z2RAReoXUVgllWAsFCHsKcpB7wYz8qUV6uCQ4Gjzc2N-rs3PrfkddKwNfTVQa2ybhsXqO99aglcwqVhERJSUUlkBckuS-kRCDKS0Sr-D3gww4bAm9UFL0apF33Gt0afj8DB10FMLm6tXDbBzULwDqJ257PYATIzu9xYWR__95Gt0d3KWT_n0dPbpObqnf4h2w2H6Au2vV716CfHVWrwyq-kP7xMlDA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSFd2l4GokTUp628-BGl6xaaFYVUKniEsWOA2mz2dVmc1h-AL-bsb2pNhWnXp2J4mQ-e2bkL98g9D6QzOehEHYFu59NY0_aRVIwmycFIUlYMF-LJGWz8OiMfjln5zutvjRpX_DaaZu509a_NbdyORfuwBNzT7NJBGETYpe7LCv3NroDazZIdgr1C5P4EkKYOceEMixxq3o-76EgDDyHRVAnqOZFBAAIVuEoKGnt_v8lnNd5kzuBaPoQ_RxewfBPLp1-zR3x55q6443e8RF6sE1P8Sdj8hjdku0TdNc0rNw8RX8BVfg4y9LZ9xQrCuLmI9ZDmrrYFBt8aHhfuM6yvpW4aEuczkr1m1cDSMcT2TQdrluc6RYhEDfxZMSIxd_q7lIZGCn1WuCTftl3OF1tjL7souu7Z-hsmv6YHNnbTg62oCFb2wLSuiIgglZUQD4ay7jyhUwqTjl4gikNJNhMAB0iEiEVUGIxsPJLAeWpT2RI9tFeu2jlAcJxSSIlg-8x4VOeeEUYVHHFGQt4AHuLtNCHwZX50gh25FDoKAjkGgK5gkBuIGChQ-XsK0Olta0HFqtf-dYbeQWTinhIeEkpFRUguCSJRwTkQlKp9Vvo3QCVHNamOnApWrnou1xp9al8PEgs9NxA5-pRA_QsFI1ANZrL-ApARet_b6Hx4sZ3vkX3Tj9P85Pj2deX6L76HioaB8krtLde9fI1pFlr_kYvqH8XqCeM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+IMMENSE+Study%3A+The+Interplay+Between+iMMune+and+ENdothelial+Cells+in+Mediating+Cardiovascular+Risk+in+Systemic+Lupus+Erythematosus&rft.jtitle=Frontiers+in+immunology&rft.au=Bortoluzzi%2C+Alessandra&rft.au=Chighizola%2C+Cecilia+Beatrice&rft.au=Fredi%2C+Micaela&rft.au=Raschi%2C+Elena&rft.date=2020-10-29&rft.eissn=1664-3224&rft.volume=11&rft.spage=572876&rft_id=info:doi/10.3389%2Ffimmu.2020.572876&rft_id=info%3Apmid%2F33193356&rft.externalDocID=33193356
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon